Resume-aware faculty matching

Find professors who actually fit you

Review faculty evidence in public, then use the workspace to turn your background into a shortlist, outreach, and meeting prep.

Profile-awarePaper evidenceSix agents
David Campbell

David Campbell

· Professor (Physics, ECE, and MSE), Director of Graduate Studies

Boston University · Physics

Active 1967–2025

h-index60
Citations12.3k
Papers552118 last 5y
Funding—

Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.

See your match with David Campbell — sign in to PhdFit.Sign in

About

David Campbell is a Professor of Physics, Electrical and Computer Engineering (ECE), and Materials Science and Engineering (MSE) at Boston University, serving as the Director of Graduate Studies. His research interests encompass correlated electronic systems, nonlinear excitations, and non-equilibrium phenomena. He has investigated correlated electronic systems in reduced spatial dimensions, including conducting polymers, superconducting organic charge transfer salts, graphene, and other two-dimensional electronic membranes, often employing a version of the functional Renormalization Group (fRG) that he developed with colleagues. Campbell has a long-standing interest in solitons and nonlinear excitations, studying intrinsic localized modes (ILMs) in solids and Bose-Einstein Condensates (BECs) trapped in optical lattices. Additionally, he explores non-equilibrium problems, particularly the metastable states in Fermi-Pasta-Ulam-Tsingou (FPUT) simulations, which delay or prevent the approach to thermodynamic equilibrium. His contributions have significantly advanced understanding in these areas, supported by numerous publications and recognition through prestigious awards and fellowships.

Research topics

  • Computer Science
  • Physics
  • Classical mechanics
  • Mechanical engineering
  • Medicine
  • Statistical physics
  • Surgery
  • Aerospace engineering
  • Quantum mechanics
  • Mathematics

Selected publications

  • Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients

    JAMA Cardiology · 2022 · 169 citations

    Importance: In patients with severe aortic valve stenosis at intermediate surgical risk, transcatheter aortic valve replacement (TAVR) with a self-expanding supra-annular valve was noninferior to surgery for all-cause mortality or disabling stroke at 2 years. Comparisons of longer-term clinical and hemodynamic outcomes in these patients are limited. Objective: To report prespecified secondary 5-year outcomes from the Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve…

  • Adiabatic Eigenstate Deformations as a Sensitive Probe for Quantum Chaos

    Physical Review X · 2020 · 138 citations

    In the past decades, it was recognized that quantum chaos, which is essential for the emergence of statistical mechanics and thermodynamics, manifests itself in the effective description of the eigenstates of chaotic Hamiltonians through random matrix ensembles and the eigenstate thermalization hypothesis. Standard measures of chaos in quantum many-body systems are level statistics and the spectral form factor. In this work, we show that the norm of the adiabatic gauge potential, the generator o…

  • Science and technology of the Casimir effect

    Physics Today · 2021 · 34 citations

    Caused by simple fluctuations in space, the Casimir effect may validate theories of the cosmological constant and allow for measurements of ultrasmall magnetic fields.

  • Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09)

    Journal of Clinical Oncology · 2024-06-05 · 23 citations

    article

    PURPOSE Bempegaldesleukin (BEMPEG) is a pegylated interleukin (IL)-2 cytokine prodrug engineered to provide controlled and sustained activation of the clinically validated IL-2 pathway, with the goal of preferentially activating and expanding effector CD8 + T cells and natural killer cells over immunosuppressive regulator T cells in the tumor microenvironment. The open-label, phase III randomized controlled PIVOT-09 trial investigated the efficacy and safety of BEMPEG plus nivolumab (NIVO) as fi…

  • Zigzag materials: Selective interchain couplings control the coexistence of one-dimensional physics and deviations from it

    Physical Review Research · 2023-10-18 · 7 citations

    articleOpen accessSenior author

    The coexistence in the low-temperature spin-conducting phases of the zigzag materials <a:math xmlns:a="http://www.w3.org/1998/Math/MathML"><a:mrow><a:msub><a:mi>BaCo</a:mi><a:mn>2</a:mn></a:msub><a:msub><a:mi mathvariant="normal">V</a:mi><a:mn>2</a:mn></a:msub><a:msub><a:mi mathvariant="normal">O</a:mi><a:mn>8</a:mn></a:msub></a:mrow></a:math> and <d:math xmlns:d="http://www.w3.org/1998/Math/MathML"><d:mrow><d:msub><d:mi>SrCo</d:mi><d:mn>2</d:mn></d:msub><d:msub><d:mi mathvariant="normal">V</d:m…

Frequent coauthors

  • D. J. Bishop

    Royal Society of Chemistry

    56 shared
  • Matthias Imboden

    51 shared
  • A. H. Castro Neto

    National University of Singapore

    48 shared
  • Lawrence Barrett

    Boston University

    45 shared
  • Ros Draper

    36 shared
  • Simon Chowdhury

    St Thomas' Hospital

    34 shared
  • Andrea Loehr

    Clovis Oncology (United States)

    32 shared
  • Ray McDermott

    32 shared

Awards & honors

  • J. Robert Oppenheimer Fellow, Los Alamos Scientific Laborato…
  • American Association for the Advancement of Science, Fellow…
  • American Physical Society, Fellow (1990)
  • Toshiba Lecturer, Keio University Tokyo, Japan (1994)
  • Stanislaw M. Ulam Scholar, Center for Nonlinear Studies, Los…

Similar researchers at Boston University

  • Resume-aware match score
  • Save to shortlist
  • AI-drafted outreach

See your match with David Campbell

PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.

  • Free to start
  • No credit card
  • 30-second signup